Suppressing ovulation through a new kind of hormone-releasing drug therapy can help lessen the effects of many disorders that are worsened by hormonal changes in a woman’s menstrual cycle, according to a new study published in the Archives of Internal Medicine.
The gonadotropin-releasing hormone agonists, tested by the Queen’s University researchers, can decrease the symptoms of migraine headaches, improve blood sugar control, and lessen other symptoms associated with epilepsy, arthritis, and asthma, all of which vary in severity during a woman’s menstrual cycle. In addition, the ovarian suppression related to the hormone can be used by doctors to determine whether a condition is menstrual-related, according to researchers. The therapy must be used in conjunction with estrogen-replacement therapy in order to prevent the early onset of some menopausal symptoms.
